Page 75 - Read Online
P. 75
Ahmed et al. Vessel Plus 2018;2:36 I http://dx.doi.org/10.20517/2574-1209.2018.51 Page 11 of 13
27. Haga JH, Li YS, Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech
2007;40:947-60.
28. Brozovich FV, Nicholson CJ, Degen CV, Gao YZ, Aggarwal M, et al. Mechanisms of vascular smooth muscle contraction and the basis
for pharmacologic treatment of smooth muscle disorders. Pharmacol Rev 2016;68:476-532.
29. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development
and disease. Annu Rev Physiol 2012;74:13-40.
30. Owens GK. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp
2007;283:174-91.
31. Yamin R, Morgan KG. Deciphering actin cytoskeletal function in the contractile vascular smooth muscle cell. J Physiol
2012;590:4145-54.
32. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, et al. A monoclonal antibody against alpha-smooth muscle actin: a new
probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-96.
33. Papakonstanti EA, Stournaras C. Cell responses regulated by early reorganization of actin cytoskeleton. FEBS Lett 2008;582:2120-7.
34. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 2007;45:A25-32.
35. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth
Heart J 2007;15:100-8.
36. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ 2003;27:201-6.
37. Eddinger TJ, Meer DP. Myosin II isoforms in smooth muscle: heterogeneity and function. Am J Physiol Cell Physiol 2007;293:C493-508.
38. Löfgren M, Ekblad E, Morano I, Arner A. Nonmuscle myosin motor of smooth muscle. J Gen Physiol 2003;121:301-10.
39. Woodrum DA, Brophy CM. The paradox of smooth muscle physiology. Mol Cell Endocrinol 2001;177:135-43.
40. Martinsen A, Dessy C, Morel N. Regulation of calcium channels in smooth muscle: new insights into the role of myosin light chain
kinase. Channels (Austin) 2014;8:402-13.
41. Fridlyand LE, Philipson LH. Pancreatic beta cell G-protein coupled receptors and second messenger interactions: a systems biology
computational analysis. PloS One 2016;11:e0152869.
42. Inagami T, Eguchi S, Tsuzuki S, Ichiki T. Angiotensin II receptors AT1 and AT2: new mechanisms of signaling and antagonistic effects
of AT1 and AT2. In: Dhalla NS, Zahradka P, Dixon IMC, Beamish RE, editors. Angiotensin II receptor blockade physiological and
clinical implications. Boston: Springer; 1998. pp. 129-39.
43. Walsh MP. Calmodulin and its roles in skeletal muscle function. Can Anaesth Soc J 1983;30:390-8.
44. Lee S, Kumar S. Actomyosin stress fiber mechanosensing in 2D and 3D. F1000Res 2016; doi: 10.12688/f1000research.8800.1.
45. Schwartz MA. Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2010;2:a005066.
46. Bar-Sagi D, Hall A. Ras and Rho GTPases: a family reunion. Cell 2000;103:227-38.
47. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle
cells. Trends Pharmacol Sci 2001;22:32-9.
48. Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken)
2010;67:545-54.
49. Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007;50:17-24.
50. Murányi A, Derkach D, Erdodi F, Kiss A, Ito M, et al. Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit:
inhibitory effects and occurrence in A7r5 cells. FEBS Lett 2005;579:6611-5.
51. Burute M, Thery M. Spatial segregation between cell-cell and cell-matrix adhesions. Curr Opin Cell Biol 2012;24:628-36.
52. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, et al. Cell-cell adhesion and communication. Molecular cell biology. New
York: W. H. Freeman; 2000.
53. Sun Z, Parrish AR, Hill MA, Meininger GA. N-cadherin, a vascular smooth muscle cell-cell adhesion molecule: function and signaling
for vasomotor control. Microcirculation 2014;21:208-18.
54. Lyon CA, Johnson JL, White S, Sala-Newby GB, George SJ. EC4, a truncation of soluble N-cadherin, reduces vascular smooth muscle
cell apoptosis and markers of atherosclerotic plaque instability. Mol Ther Methods Clin Dev 2014;1:14004.
55. Lyon CA, Wadey KS, George SJ. Soluble N-cadherin: a novel inhibitor of VSMC proliferation and intimal thickening. Vascul
Pharmacol 2016;78:53-62.
56. Lyon CA, Koutsouki E, Aguilera CM, Blaschuk OW, George SJ. Inhibition of N-cadherin retards smooth muscle cell migration and
intimal thickening via induction of apoptosis. J Vasc Surg 2010;52:1301-9.
57. Perez TD, Nelson WJ. Cadherin adhesion: mechanisms and molecular interactions. Handb Exp Pharmacol 2004; doi: 10.1007/978-3-
540-68170-0_1.
58. Shapiro L, Weis WI. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 2009;1:a003053.
59. Weis WI, Nelson WJ. Re-solving the cadherin-catenin-actin conundrum. J Biol Chem 2006;281:35593-7.
60. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004;1692:103-19.
61. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol 2007;213:565-73.
62. Suki B, Parameswaran H, Imsirovic J, Bartolák-Suki E. Regulatory roles of fluctuation-driven mechanotransduction in cell function.
Physiology (Bethesda) 2016;31:346-58.
63. Bachir AI, Zareno J, Moissoglu K, Plow EF, Gratton E, et al. Integrin-associated complexes form hierarchically with variable
stoichiometry in nascent adhesions. Curr Biol 2014;24:1845-53.